LIFR, acting as a receptor subunit for leukaemia inhibitor factor (LIF), is said to boost gastric cancer cell proliferation, migration, and invasion through the LIFR-Hippo-YAP pathway42. This evidence concerns the gene LIF and gastric cancer.